The Motley Fool Investing Philosophy: We generally recommend investors buy shares of at least 25 stocks and hold them for at least 5 years. Learn More
| 1 Year | 5 Year | 5 Year Annualized | Since IPO | |
|---|---|---|---|---|
| QDEL | -23.37% | -87.99% | -34.54% | +75% |
| S&P | +16.23% | +94.45% | +14.22% | +3,916% |
QuidelOrtho Corp. operates as a vitro diagnostics company. It is focused on developing and manufacturing diagnostic products. The company was founded on May 27, 2022 and is headquartered in San Diego, CA.
| Q2 2025 | YOY Change | |
|---|---|---|
| Revenue | $615.10M | -3.3% |
| Gross Profit | $228.30M | 2.1% |
| Gross Margin | 37.12% | 2.0% |
| Market Cap | $1.95B | -12.4% |
| Market Cap / Employee | $0.30M | 0.0% |
| Employees | 6.6K | -7.0% |
| Net Income | -$255.40M | -72.9% |
| EBITDA | $109.80M | 28.0% |
Currently no data to display
Currently no data to display.
Currently no data to display.
| Q2 2025 | YOY Change | |
|---|---|---|
| Net Cash | $151.70M | 41.8% |
| Accounts Receivable | $309.20M | -1.4% |
| Inventory | 578.7 | -3.9% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Long Term Debt | $2.23B | -6.6% |
| Short Term Debt | $564.20M | 46.2% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Return On Assets | -6.76% | 17.6% |
| Return On Invested Capital | 11.79% | -10.0% |
| Q2 2025 | YOY Change | |
|---|---|---|
| Free Cash Flow | -$84.30M | 36.7% |
| Operating Free Cash Flow | -$46.80M | 52.2% |
| Metric | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | YoY Change |
|---|---|---|---|---|---|
| Price to Book | 0.96 | 0.94 | 0.79 | 0.65 | -3.25% |
| Price to Sales | 1.09 | 1.07 | 0.85 | 0.71 | -9.60% |
| Price to Tangible Book Value | -8.07 | -7.88 | -5.87 | -5.24 | -25.83% |
| Price to Free Cash Flow TTM | 69.96 | 150.35 | - | ||
| Enterprise Value to EBITDA | 34.37 | 44.52 | 31.15 | 41.85 | -26.61% |
| Free Cash Flow Yield | 1.4% | 0.7% | - | ||
| Return on Equity | -45.8% | -50.7% | -10.6% | -14.8% | -67.47% |
| Total Debt | $2.76B | $2.68B | $2.69B | $2.79B | 0.79% |
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.
